Compare · AVAH vs EUDA
AVAH vs EUDA
Side-by-side comparison of Aveanna Healthcare Holdings Inc. (AVAH) and EUDA Health Holdings Limited (EUDA): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both AVAH and EUDA operate in Medical/Nursing Services (Health Care), so they compete in similar markets.
- AVAH is the larger of the two at $2.99B, about 64.8x EUDA ($46.1M).
- Over the past year, AVAH is up 83.2% and EUDA is down 66.8% - AVAH leads by 150.0 points.
- AVAH has been more active in the news (18 items in the past 4 weeks vs 2 for EUDA).
- AVAH has more recent analyst coverage (22 ratings vs 0 for EUDA).
- Company
- Aveanna Healthcare Holdings Inc.
- EUDA Health Holdings Limited
- Price
- $13.61-0.73%
- $16.60+10.52%
- Market cap
- $2.99B
- $46.1M
- 1M return
- +40.94%
- +10.52%
- 1Y return
- +83.24%
- -66.80%
- Industry
- Medical/Nursing Services
- Medical/Nursing Services
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2021
- 2021
- News (4w)
- 18
- 2
- Recent ratings
- 22
- 0
Aveanna Healthcare Holdings Inc.
Aveanna Healthcare Holdings Inc., a diversified home care platform company, provides private duty nursing (PDN), adult home health and hospice, home-based pediatric therapy, and enteral nutrition services in the United States. Its patient- centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals. The company operates through three segments: Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). The PDS segment offers PDN services, which include in-home skilled nursing services to medically fragile children; nursing services in school settings in which our caregivers accompany patients to school; services to patients in its pediatric day healthcare centers; unskilled nursing services; and employer of record support services, as well as in-clinic and home-based pediatric therapy services, such as physical, occupational, and speech services. The HHH segment provides home health services, including in-home skilled nursing services; physical, occupational, and speech therapy services; and medical social and aide services, as well as hospice services for patients and their families when a life-limiting illness no longer responds to cure-oriented treatments. The MS segment offers a line of durable medical equipment and enteral nutrition supplies to adults and children delivered on a periodic or as-needed basis. The company was incorporated in 2016 and is headquartered in Atlanta, Georgia.
Latest AVAH
- Aveanna to Participate in the 2026 Jefferies Healthcare Services and Technology Conference
- Large owner J.H. Whitney Equity Partners Vii, Llc sold $169,579,886 worth of shares (14,746,077 units at $11.50) (SEC Form 4)
- Large owner Williams Robert M Jr sold $192,625,023 worth of shares (16,750,002 units at $11.50) (SEC Form 4)
- Large owner Vigano Paul R sold $192,625,023 worth of shares (16,750,002 units at $11.50) (SEC Form 4)
- Chief Administrative Officer Reisz Edwin C. sold $575,000 worth of shares (50,000 units at $11.50), decreasing direct ownership by 3% to 1,397,897 units (SEC Form 4)
- Chief Executive Officer Shaner Jeff sold $1,035,000 worth of shares (90,000 units at $11.50), decreasing direct ownership by 3% to 2,561,972 units (SEC Form 4)
- Director Windley Rodney D sold $2,070,000 worth of shares (180,000 units at $11.50), decreasing direct ownership by 8% to 2,078,017 units (SEC Form 4)
- SEC Form 8-K filed by Aveanna Healthcare Holdings Inc.
- SEC Form 424B4 filed by Aveanna Healthcare Holdings Inc.
- Aveanna Announces Pricing of Secondary Offering of Common Stock
Latest EUDA
- SEC Form 424B3 filed by EUDA Health Holdings Limited
- SEC Form EFFECT filed by EUDA Health Holdings Limited
- Amendment: SEC Form F-3/A filed by EUDA Health Holdings Limited
- SEC Form 6-K filed by EUDA Health Holdings Limited
- EUDA Health Announces Collaboration to Advance an Integrated iPSC Cell Therapy Program for Oncology and Wellness • Targets global distribution for innovative Oncology products
- SEC Form 6-K filed by EUDA Health Holdings Limited
- EUDA Health Signs Important Tri-Party Memorandum of Understanding with GO POSB Organoids and Shenzhen Inno to Significantly Advance Next-Generation iPSC and NK-TCR Cell Therapies
- SEC Form 424B5 filed by EUDA Health Holdings Limited
- Amendment: SEC Form F-3/A filed by EUDA Health Holdings Limited
- Amendment: SEC Form F-3/A filed by EUDA Health Holdings Limited